DailyDoctor Archive Specialties Get app
Back to the 8 September 2026 edition

Research · 04 of 06

Urate deposits dissolve throughout, not from the outside in

Tell patients starting urate-lowering therapy that deposits shrink fastest in the first six months and dissolve throughout rather than from the surface, and keep monitoring serum urate rather than repeat imaging.

Design
prospective longitudinal dual-energy CT imaging study with serial superimposed scans
Population
people with microscopically verified gout initiating or increasing urate-lowering therapy, knees and feet imaged
Primary outcome
change in density and effective atomic number of monosodium urate deposits at baseline, 3, 6 and 12 months
Effect
density fell in all patients, equally in whole lesion and core, faster in months 0-6 than 6-12; effective atomic numbers unchanged

People with crystal-proven gout starting or increasing urate-lowering therapy had dual-energy CT of knees and feet at baseline, three, six and twelve months. Every colour-coded lesion in the first metatarsophalangeal joint and the patellar tendons was outlined, its core tracked separately, and the four scans superimposed so the same deposit could be followed over time.

Density fell in every patient. It fell at much the same rate in the outer shell and the core, and at much the same rate at the foot and the knee, which is not what a melting-ice-cube model of tophus resolution would predict. Most of the fall happened in the first six months, following something closer to first-order kinetics than a straight line. Effective atomic numbers did not change, so the deposits were not calcifying as they shrank.

This is imaging physiology rather than an outcome study — no flare rates, no function, no numbers of patients large enough to generalise confidently. Its practical value is in what you tell a patient who asks how long this takes. Deposits respond throughout their volume from the start, the fastest change is in the first half-year, and a deposit that is still visible at twelve months is not evidence that the therapy has failed.

  • Set expectations at ULT initiation: most measurable change happens in the first six months
  • A persisting tophus on imaging at a year does not by itself mean treatment failure
  • Keep judging response on serum urate and flare frequency, not on imaging
  • There was no sign of deposits calcifying during treatment
  • Dual-energy CT remains a research and diagnostic tool here, not a monitoring test

The statistics, in plain English

The study reports the shape of change rather than a single effect size, and with a small imaging cohort the distinction between first-order and linear decline is a description of a trend, not a formally powered comparison. Because every lesion in each patient contributes, measurements within a patient are not independent, so apparent consistency across lesions partly reflects that clustering.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

vasculitislupusctdgoutra

Tomorrow morning, before your first patient

One edition a day for rheumatology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app